Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.008 | 0.904 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0016 | 0 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0016 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.904 | 0.904 |
Mycobacterium ulcerans | dehydrogenase | 0.0016 | 0 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0016 | 0 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0016 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0016 | 0 | 0.5 |
Onchocerca volvulus | 0.0087 | 1 | 0.5 | |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.008 | 0.904 | 1 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0016 | 0 | 0.5 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0016 | 0 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0016 | 0 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0016 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0016 | 0 | 0.5 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0016 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.096 | 0.096 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0016 | 0 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.008 | 0.904 | 1 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0016 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0016 | 0 | 0.5 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0016 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.904 | 0.904 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0023 | 0.096 | 0.096 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0016 | 0 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0016 | 0 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0016 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0016 | 0 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0016 | 0 | 0.5 |
Mycobacterium ulcerans | monoamine oxidase | 0.0016 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.137 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.022 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.